{"SPADE_UN_27605": {"Sequence Information": {"Peptide Name": "LL-37 (17-29)", "Sequence": "FKRIVQRIKDFLR", "Sequence Length": 13, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "2FBS", "UniProt Entry": [{"uniprotId": "P49913", "uniprotUrl": "http://www.uniprot.org/uniprot/P49913", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.", "Pubmed ID": "16637646", "Reference": "J Am Chem Soc. 2006;128:5776-5785", "Author": "Li X, Li Y, Han H, Miller DW, Wang G", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/16637646"}, {"Title": "High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7.", "Pubmed ID": "28178190", "Reference": "Int J Mol Sci. 2017;:", "Author": "Tan T, Wu D, Li W, Zheng X, Shan A", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28178190"}, {"Title": "LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.", "Pubmed ID": "28161291", "Reference": "Biochim Biophys Acta. 2017;1859:722-733", "Author": "Rajasekaran G, Kim EY, Shin SY", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28161291"}, {"Title": "Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents.", "Pubmed ID": "32567085", "Reference": "J Pept Sci. 2020;26:e3254", "Author": "Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Panou-Pomonis E", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32567085"}], "Mass": 1719.08, "PI": 11.72, "Net Charge": 4, "Hydrophobicity": -0.44, "Frequent Amino Acids": "RFI", "Absent Amino Acids": "ACEGHMNOPSTUWY", "Basic Residues": 5, "Acidic Residues": 1, "Hydrophobic Residues": 6, "Polar Residues": 7, "Positive Residues": 5, "Negative Residues": 1, "SPADE ID": "SPADE_UN_27605", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02277", "Similarity": 1.0, "Sequence": "GDFFRKSKEKIGKEFKRIVQRIKDFLRN"}, {"SPADE_ID": "SPADE_N_02334", "Similarity": 1.0, "Sequence": "LLGDFFRKAREKIGEEFKRIVQRIKDFLRNLVPRTES"}, {"SPADE_ID": "SPADE_N_03100", "Similarity": 1.0, "Sequence": "KSKEKIGKEFKRIVQRIKDFLRNLVPR"}], "Hemolytic Activity": "Human brain microvascular endothelial cells HBMEC:50% Cell death=55±2 µM,Human erythrocytes:50% Hemolysis=>256 µM,Human Lung Fibroblasts:IC50=29.3 µg/ml", "Target Organism": "Escherichia coli K-12(MIC=40µM),Human epithelial carcinoma KBv(LC50=60±0µM),Human epithelial carcinoma KB(LC50=57±3µM),Escherichia coli ATCC 25922(MIC=16µM),Escherichia coli UB1005(MIC=16µM),Pseudomonas aeruginosa ATCC 27853(MIC=8µM),Pseudomonas aeruginosa PAO1(MIC=16µM),Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028(MIC=32µM),Salmonella typhimurium ATCC 7731(MIC=16µM),Staphylococcus aureus ATCC 29213(MIC=16µM),Enterococcus faecalis ATCC 29212(MIC=32µM),Bacillus subtilis CMCC 63501(MIC=16µM),Staphylococcus epidermidis ATCC 12228(MIC=8µM),Escherichia coli KCTC 1682(MIC=16µM),Pseudomonas aeruginosa KCTC 1637(MIC=32µM),Salmonella typhimurium KCTC 1926(MIC=16µM),Bacillus subtilis KCTC 3068(MIC=4µM),Staphylococcus epidermidis KCTC 1917(MIC=16µM),Staphylococcus aureus KCTC 1621(MIC=16µM),Escherichia coli DH5alpha(MIC=200µg/ml),Pseudomonas aeruginosa PAO1(no activity data),Zymomonas mobilis ATCC 10988(no activity data),Bacillus subtilis DELTA(no activity data),Mycobacterium smegmatis mc2-155(MIC=50µg/ml),Candida parapsilosis(MIC=200µg/ml),Human lung carcinoma A549(IC50=20.1µg/ml)"}}}